1 / 96

Disclaimer

Disclaimer.

joanneg
Download Presentation

Disclaimer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence. Notes: Based on data received 2019-03. This is surveillance data, hence for the last month, the data may be incomplete.

  2. Rubella cases: Afghanistan 15 10 Number of cases 5 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Notes: Based on data received 2019-03. This is surveillance data, hence for the last month, the data may be incomplete. Lab Month of onset Afghanistan age distribution, vaccination status, and incidence, 2018-02 to 2019-01 10 8.9 15 10 Incidence rate per 1,000,000 Number of cases 5 3.8 5 1.4 1.1 0.3 0.2 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  3. Rubella cases: Algeria Cov: 45% 20 Number of cases 10 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Algeria age distribution, vaccination status, and incidence, 2018-02 to 2019-01 6 1.4 1.5 1.1 1.1 4 1 Incidence rate per 1,000,000 Number of cases 2 0.5 0.3 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  4. Rubella cases: Angola Cov: 93% 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Angola age distribution, vaccination status, and incidence, 2018-02 to 2019-01 15 3.2 2.8 3 10 2 2 Incidence rate per 1,000,000 Number of cases 1.2 5 0.8 1 0.3 0.2 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  5. Rubella cases: Bangladesh SIA (9 M-<5 Y) SIA (6 M-<15 Y) Cov: 99.8% Cov: 107% 60 40 Number of cases 20 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Bangladesh age distribution, vaccination status, and incidence, 2018-02 to 2019-01 80 19.4 20 60 15 Incidence rate per 1,000,000 Number of cases 40 10 5.8 4.3 5 20 2.1 1.4 0.3 0.3 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  6. Rubella cases: Belarus 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Belarus age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 1 0.9 Incidence rate per 1,000,000 Number of cases 1 0.5 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  7. Rubella cases: Benin 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Benin age distribution, vaccination status, and incidence, 2018-02 to 2019-01 6 3 3 4 2 Incidence rate per 1,000,000 Number of cases 1.5 1.3 2 1 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  8. Rubella cases: Bhutan 4 3 Number of cases 2 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Bhutan age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 14 15 10 Incidence rate per 1,000,000 Number of cases 1 5 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  9. Rubella cases: Bosnia and Herzegovina 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Bosnia and Herzegovina age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 30 30 20 Incidence rate per 1,000,000 Number of cases 1 10 0.5 0 0 0 0 0 0 0 5-9 years 10-14 years 15-19 years 20-29 years 30+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  10. Rubella cases: Botswana 3 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Botswana age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 18.6 20 15 Incidence rate per 1,000,000 Number of cases 1 10 4.7 4.2 5 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  11. Rubella cases: Bulgaria 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Bulgaria age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 3.7 4 3 Incidence rate per 1,000,000 Number of cases 1 2 1 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  12. Rubella cases: Burkina Faso 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Burkina Faso age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 0.7 2 0.5 Incidence rate per 1,000,000 Number of cases 0.3 1 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  13. Rubella cases: Burundi 4 3 Number of cases 2 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Burundi age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 2.2 2 Incidence rate per 1,000,000 Number of cases 1 0.8 1 0.6 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  14. Rubella cases: Cambodia 4 3 Number of cases 2 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Cambodia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 4 1 0.9 3 0.7 0.6 Incidence rate per 1,000,000 Number of cases 2 0.5 1 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  15. Rubella cases: Cameroon 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Cameroon age distribution, vaccination status, and incidence, 2018-02 to 2019-01 4 3.8 4 3 3 Incidence rate per 1,000,000 Number of cases 2 2 0.7 1 1 0.6 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  16. Rubella cases: Central African Republic 10 Number of cases 5 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Central African Republic age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 4 3.4 3 2 Incidence rate per 1,000,000 Number of cases 2 1.6 1 1 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  17. Rubella cases: Chad 20 Number of cases 10 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Chad age distribution, vaccination status, and incidence, 2018-02 to 2019-01 30 10.9 25 10 20 7.3 Incidence rate per 1,000,000 Number of cases 15 5 10 1.8 1.6 5 0.7 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  18. Rubella cases: China 800 600 Number of cases 400 200 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset

  19. Rubella cases: Congo SIA (9 M-14 Y) 20 Number of cases 10 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Congo age distribution, vaccination status, and incidence, 2018-02 to 2019-01 94.5 100 60 80 70 60 40 Incidence rate per 1,000,000 Number of cases 40 25.1 20 20 10.8 4.7 1.1 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  20. Rubella cases: Cote d'Ivoire SIA (9 M-14 Y) 120 Cov: 98.3% 100 80 Number of cases 60 40 20 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Cote d'Ivoire age distribution, vaccination status, and incidence, 2018-02 to 2019-01 23 25 40 20 14.2 15 Incidence rate per 1,000,000 Number of cases 9.2 20 10 4.3 2.8 5 1.8 0.5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  21. Rubella cases: Czech Republic 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Czech Republic age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 0.4 Incidence rate per 1,000,000 Number of cases 1 0.2 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  22. Rubella cases: Democratic Republic of the Congo 120 100 80 Number of cases 60 40 20 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Democratic Republic of the Congo age distribution, vaccination status, and incidence, 2018-02 to 2019-01 120 10 9.1 8.7 100 80 Incidence rate per 1,000,000 4.7 Number of cases 5 60 40 1.8 20 0.3 0.3 0.2 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  23. Rubella cases: Egypt 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Egypt age distribution, vaccination status, and incidence, 2018-02 to 2019-01 0.6 6 0.5 0.4 4 Incidence rate per 1,000,000 Number of cases 2 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  24. Rubella cases: Equatorial Guinea 3 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Equatorial Guinea age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 36.5 40 30 2 Incidence rate per 1,000,000 Number of cases 18.2 20 1 9.9 10 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  25. Rubella cases: Eritrea SIA (9 M-14 Y) 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Eritrea age distribution, vaccination status, and incidence, 2018-02 to 2019-01 4 4.6 3 4 2.6 Incidence rate per 1,000,000 Number of cases 2 2 1 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  26. Rubella cases: Ethiopia 150 100 Number of cases 50 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Ethiopia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 25 22 19.9 300 20 15 200 Incidence rate per 1,000,000 Number of cases 10 100 4.1 5 2.3 1.1 0.4 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  27. Rubella cases: Gabon 3 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Gabon age distribution, vaccination status, and incidence, 2018-02 to 2019-01 6 25 21.1 20 4 15 Incidence rate per 1,000,000 Number of cases 10 2 5 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  28. Rubella cases: Gambia 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Gambia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 3.3 3 Incidence rate per 1,000,000 2 Number of cases 1 1 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  29. Rubella cases: Georgia 4 3 Number of cases 2 1 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Georgia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 18.8 20 15 Incidence rate per 1,000,000 Number of cases 1 10 5 1.8 0.5 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  30. Rubella cases: Germany 15 10 Number of cases 5 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Germany age distribution, vaccination status, and incidence, 2018-02 to 2019-01 10 20 8.8 6.7 15 Incidence rate per 1,000,000 Number of cases 5 10 1.8 5 0.6 0.3 0.2 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  31. Rubella cases: Ghana Cov: 94.6% 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Ghana age distribution, vaccination status, and incidence, 2018-02 to 2019-01 20 6 6 5 15 4 Incidence rate per 1,000,000 Number of cases 10 2 5 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  32. Rubella cases: Guinea 80 60 Number of cases 40 20 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Guinea age distribution, vaccination status, and incidence, 2018-02 to 2019-01 8 4 4 6 3.1 3 Incidence rate per 1,000,000 Number of cases 4 2 1.3 2 1 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  33. Rubella cases: India SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) SIA (9 M-15 Y) Cov: 101.9% Cov: 106.9% Cov: 100.9% Cov: 101.6% Cov: 96.7% Cov: 97.1% Cov: 101.4% Cov: 84.8% Cov: 98.3% Cov: 101.1% Cov: 96.9% Cov: 93.98% Cov: 100% Cov: 99% Cov: 95.98% Cov: 96.7% Cov: 96% Cov: 95.1% Cov: 93.5% Cov: 99.6% Cov: 97.8% 1000 800 600 Number of cases 400 200 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA India age distribution, vaccination status, and incidence, 2018-02 to 2019-01 1000 6.3 5.8 800 6 4.9 600 4 Incidence rate per 1,000,000 3.2 Number of cases 400 2 200 0.7 0.3 0.1 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  34. Rubella cases: Indonesia SIA (9 M-15 Y) SIA (9 M-15 Y) Cov: 101% Cov: 73% 600 400 Number of cases 200 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Indonesia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 20 16.8 16.7 400 14.8 15 300 Incidence rate per 1,000,000 Number of cases 10 7.6 200 5 5 100 1.7 0.3 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  35. Rubella cases: Ireland 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Ireland age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 5.6 6 2 3.5 4 Incidence rate per 1,000,000 Number of cases 1 2 1 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  36. Rubella cases: Israel 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Israel age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 0.8 0.6 0.5 Incidence rate per 1,000,000 Number of cases 1 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  37. Rubella cases: Italy 15 10 Number of cases 5 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Italy age distribution, vaccination status, and incidence, 2018-02 to 2019-01 8 4 4 6 2.9 3 Incidence rate per 1,000,000 Number of cases 4 2 2 1 0.5 0.4 0.3 0.2 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  38. Rubella cases: Japan 300 200 Number of cases 100 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Japan age distribution, vaccination status, and incidence, 2018-02 to 2019-01 200 8 6.7 150 6 4.5 Incidence rate per 1,000,000 Number of cases 4 100 2.2 1.9 2 50 0.7 0.5 0.4 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  39. Rubella cases: Kazakhstan 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Kazakhstan age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 0.4 Incidence rate per 1,000,000 Number of cases 1 0.2 0 0 0 0 0 0 0 5-9 years 10-14 years 15-19 years 20-29 years 30+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  40. Rubella cases: Kenya 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Kenya age distribution, vaccination status, and incidence, 2018-02 to 2019-01 10 1.6 1.5 1.3 1 Incidence rate per 1,000,000 Number of cases 0.8 5 0.5 0.5 0.2 0.1 0.1 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  41. Rubella cases: Kuwait 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Kuwait age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 7.3 8 6 2 Incidence rate per 1,000,000 Number of cases 4 1 2 0.7 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  42. Rubella cases: Kyrgyzstan 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Kyrgyzstan age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 3.2 3 2 2 Incidence rate per 1,000,000 Number of cases 1 0.7 1 0.6 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  43. Rubella cases: Lao People's Democratic Republic 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Lao People's Democratic Republic age distribution, vaccination status, and incidence, 2018-02 to 2019-01 3 11.7 10 2 Incidence rate per 1,000,000 Number of cases 5 1 1.5 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  44. Rubella cases: Latvia 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Latvia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 10.9 10 Incidence rate per 1,000,000 Number of cases 1 5 2.5 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  45. Rubella cases: Lebanon SIA (1-15 Y) Cov: 83% 5 Number of cases 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Lebanon age distribution, vaccination status, and incidence, 2018-02 to 2019-01 6 23.6 25 20 4 15 Incidence rate per 1,000,000 Number of cases 10.6 10 2 5 2.1 0.5 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  46. Rubella cases: Liberia 40 30 Number of cases 20 10 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Liberia age distribution, vaccination status, and incidence, 2018-02 to 2019-01 30 40.8 36.1 40 20 30 Incidence rate per 1,000,000 Number of cases 19.4 20 10 10 5.8 2.4 2.2 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  47. Rubella cases: Libya SIA (3-6 Y) Cov: 101% 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Libya age distribution, vaccination status, and incidence, 2018-02 to 2019-01 15.8 6 15 11.5 4 10 Incidence rate per 1,000,000 Number of cases 6.2 2 5 1.7 1 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  48. Rubella cases: Lithuania 2 Number of cases 1 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Lithuania age distribution, vaccination status, and incidence, 2018-02 to 2019-01 2 1.9 2 Incidence rate per 1,000,000 Number of cases 1 1 0 0 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  49. Rubella cases: Madagascar 30 20 Number of cases 10 0 Clinical 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset Madagascar age distribution, vaccination status, and incidence, 2018-02 to 2019-01 4.5 15 4 3.4 10 2.5 Incidence rate per 1,000,000 2.3 Number of cases 2 1 5 0.2 0.2 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  50. Rubella cases: Malawi Cov: 102% 5 Number of cases 0 Clinical 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 2019-03 Epi Lab Month of onset National SIA Sub-national SIA Malawi age distribution, vaccination status, and incidence, 2018-02 to 2019-01 4 3.2 3 3 2 Incidence rate per 1,000,000 Number of cases 2 1.3 1 1 0.4 0 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

More Related